chevrons

Back to Previous Page

Company Quarterly Earnings Update – QNS VN – 2019 Q2

Summary of the H1 2019 results of Quang Ngai Sugar JSC (QNS VN) 

H1/2019 results: highlights
  • Revenue increased by 2.5% y/y to VND4,072 bn. QNS’s main product lines developed in opposite directions: soymilk +13.0% y/y, whereas sugar -10.9% y/y.
  • QNS’ net profit declined by 6.5% to VND 520bn. Affecting factors were 1) higher overall gross margin thanks to the soy milk segment despite the lower margin of the sugar segment; 2) higher administration expenses due to increased overhead costs related to the development of the Refined-Extra/ RE Sugar factory; and 3) the higher corporate income tax rate as a tax incentive ended.
  • The company’s financial position remains solid with cash and deposits making up 26% of total assets, the and leverage was only moderate (D/E 0.18x and D/A 0.25x).
Outlook
  • QNS’s main revenue and profit driver is its soy milk segment. This segment’s growth is supported by 1) conversion from unbranded to branded consumption; 2) QNS’s further penetration into the Southern Vietnamese market, the largest regional market in Vietnam but making up only 15% of QNS’s soy revenue.
  • The sugar segment, still a major revenue contributor, is much less significant in terms of profit contribution. In 2019, sugar (only Refined-Standard/RS) revenue is to decline by 40% (volume -30% because of unfavorable weather conditions, and price -10% as international sugar prices weakened). From 2020 onward, sugar revenue will benefit from QNS’s new RE production. We expect regional sugar prices to go up as Thailand removed some of its protection and plans to partially convert sugarcane to biochemical production items. The RE production is likely to benefit from Vietnam’s abolishment of sugar import quota and tariffs due to ASEAN Trade in Goods Agreement (ATIGA).
  • QNS’ net profit is estimated to decline by 9.7% in 2019, then +12.5% in 2020.
Recommendation

Company ratings and target prices are accessible for clients only.

If you are interested in getting full access to our paid Primary Research Materials feel free to get in touch with us at your convenience.

Our team is actively covering 50 companies in the listed Vietnamese equity space for our clients.


Featured image credit: soha.vn

Related News & Insights
Find out more navigation_button
news

Summary of 9M 2025 results and outlook of Nam Long Investment (NLG VN) The real estate market saw a rebound in new supply, supported by government initiatives that accelerated project development and sales launches. However, this recovery remains insufficient to narrow the supply-demand gap, as new launches are still concentrated in high-end and luxury segments. […]

Read Newsarrow
news

Summary of 9M 2025 results and outlook of Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD VN) Net revenue rose 8.5% y/y to VND1,355bn, driven by self-produced product sales, which accounted for 98.1% of total revenue. In Hospital channel: Revenue increased by 11.7% y/y to VND891bn, led by strong sales of key products including oncology […]

Read Newsarrow
news

Summary of 9M 2025 results and outlook of Hau Giang Pharmaceutical JSC (DHG VN) Net revenue grew 7.0% to VND3,524bn. In pharmacy channel (84.9% of total sales), early in the year, new tax and invoicing regulations posed challenges for traditional pharmacies, DHG’s main clients. It swiftly implemented support programs—including e-invoicing software assistance, promotional initiatives, and […]

Read Newsarrow
Find out more navigation_button